ASH (Ashland) Future 3-5Y EPS without NRI Growth Rate: 14.18 (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASH Ashland Inc ASH
65 GF Score
Price $71.12
GF Value $68.30
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Ashland Future 3-5Y EPS without NRI Growth Rate?

Ashland ASH -0.99% 65 Future 3-5Y EPS without NRI Growth Rate is 14.18 as of Sep. 10, 2026. GuruFocus rates ASH with a GF Score™ of 65/100 and a GF Value™ of $68.30 (Fairly Valued). The stock has 9 warning signs investors should review. Among 331 Chemicals companies, Ashland ranks worse than 71% on this metric.

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Ashland's Future 3-5Y EPS without NRI Growth Rate is 14.18.


Ashland  (NYSE:ASH) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Ashland Future 3-5Y EPS without NRI Growth Rate Related Terms


ASH vs FUL, WDFC, KWR: Future 3-5Y EPS without NRI Growth Rate Comparison

For the Specialty Chemicals subindustry, Ashland's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ashland Future 3-5Y EPS without NRI Growth Rate vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ashland's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Ashland's Future 3-5Y EPS without NRI Growth Rate falls into.


ASH
65GF Score
Ashland Inc ASH
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Future 3-5Y EPS without NRI Growth Rate of 14.18 mean?
Ashland (ASH) has a Future 3-5Y EPS without NRI Growth Rate of 14.18 as of Sep. 10, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Ashland and its competitors. According to the industry distribution chart, Ashland ranks #235 out of 331 companies in the Chemicals industry, placing it in the top 71%.
Is Ashland's Future 3-5Y EPS without NRI Growth Rate too high?
Ashland's current Future 3-5Y EPS without NRI Growth Rate is 14.18. The Chemicals industry median Future 3-5Y EPS without NRI Growth Rate is 22.31. Ashland's value of 14.18 is 36.4% below this industry median. Based on the distribution chart, Ashland ranks #235 out of 331 companies in the Chemicals industry, which is below the industry midpoint. Overall, Ashland has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ashland's Future 3-5Y EPS without NRI Growth Rate compare to FUL and WDFC?
According to the Chemicals industry distribution chart, Ashland ranks #235 out of 331 companies for Future 3-5Y EPS without NRI Growth Rate. This places Ashland in the lower half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 22.31. Ashland's value of 14.18 is 36.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Chemicals company?
The median Future 3-5Y EPS without NRI Growth Rate among Chemicals companies is 22.31, based on 331 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ashland's current Future 3-5Y EPS without NRI Growth Rate of 14.18 is 36.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Ashland and its competitors. For the Chemicals industry, the median Future 3-5Y EPS without NRI Growth Rate is 22.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ashland's current Future 3-5Y EPS without NRI Growth Rate is 14.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ashland stock overvalued right now?
Based on GuruFocus' analysis, Ashland (ASH) is currently considered Fairly Valued. The stock's GF Value™ is $68.30, compared to a current price of $71.12 — trading 4.1% above its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 14.18 and 36.4% below the Chemicals industry median of 22.31. Ashland's overall GF Score™ is 65/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Ashland (ASH), the current Future 3-5Y EPS without NRI Growth Rate is 14.18 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ashland (ASH) Overvalued in 2026?

Based on GuruFocus' analysis, Ashland stock appears to be overvalued. The current stock price of $71.12 is trading 4.1% above its estimated GF Value™ of $68.30. GuruFocus considers Ashland to be Fairly Valued.

Key valuation signals for ASH:

  • Future 3-5Y EPS without NRI Growth Rate: 14.18
  • GF Value™: $68.30 vs. price of $71.12 (4.1% above fair value)
  • GF Score™: 65/100 with 9 warning signs
  • Industry Position: 36.4% below the Chemicals median (#235 of 331)

No single metric tells the full story. See the ASH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ashland Business Description

Other Exchanges AHT:Germany
Address 8145 Blazer Drive, Wilmington, DE, USA, 19808
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
65GF Score

Get the complete analysis for ASH

Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$71.12
Price
$68.30
GF Value